BioSpace News Archive

The latest approved product, dornase alfa inhalation solution, is used together with antibiotics, bronchodilators, and steroids to control symptoms of cystic fibrosis. Generium is the first company in the world to develop and market a biosimilar of dornase alfa.

Life Science Executives Agree that Precision Medicine Represents a New Era in Drug Development, According to the Newsweek Vantage and Medidata Survey Report

Scruubs, a startup that will provide on-demand, non-emergency health and wellness services by medical professionals and drivers, has postponed its California based launches in wake of Assembly Bill Five.

Paralyzed Veterans of America is the only congressionally chartered veterans service organization dedicated solely to the benefit and representation of veterans with spinal cord injury or disease.

The Charity Golf Tournament will be held this week, September 19th, at Clovernook Country Club in Cincinnati.

Abbott (NYSE: ABT) today announced approvals in Europe for two of its life-saving pediatric devices.

PulsePoint, a data and technology company accelerating health marketing with programmatic solutions, today announced its series of new programmatically powered digital ad units for health marketers.

Northwell Health is hosting a free seminar on Thursday, September 19, to educate consumers on ways to lower their risk of developing heart problems by controlling risk factors such as stress, nutrition and high blood pressure.

Conduit Health Partners, a patient access company that develops strategies to mitigate risk and help health systems grow, and Central Logic, the leading innovator in Access Center software solutions, announced today at the Patient Flow Summit a preferred partnership to improve care access and operational efficiency for health systems nationwide.

Riverain Technologies, a leading provider of clinical artificial intelligence software used to efficiently detect lung disease at its earliest stages, has received a $15 million growth investment led by Ping An Global Voyager Fund.